Contract award record
New awardOno type DX Breast Recurrence Score Test
Tender value £405,000
Notice details
- Published
- Category
- goods
- Buyer region
- Yorkshire and The Humber
- Source
- View official notice
Public buyer and contract winner
Award value£337,500
- StartCompleted
- AwardedCurrent phase
- EndUpcoming
Work description
Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Related awards
From this contract winner
- Oncotype DX Breast Cancer Testing
£272,700 ·